Work

Real-World Clinical Characteristics and Treatment Patterns of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer: A Nationwide Korean EGFR Registry

Year: 2026
Type: article
Study design: Observational Study
Abstract: Purpose: Despite advances in epidermal growth factor receptor (EGFR)-targeted therapy for non-small cell lung cancer (NSCLC), real-world data on diagnostic and treatment patterns across all disease stages remain limited. This study used the nationwide Korean EGFR Registry to characterize contemporary clinical practice in EGFR-mutant NSCLC. Materials and Methods: A total of 1,522 patients with pathologically confirmed EGFR-mutant NSCLC were prospectively enrolled from 40 Korean institutions (June 2022-June 2024). Data on baseline clinical and molecular characteristics, biomarker testing patterns, and treatment for all lines of therapy were collected using standardized electronic case report forms. Results: The median age of the study population was 68 years, 59.7% were female, and 64.5% were never-smokers. Stage IV disease accounted for 57.8% of cases. The predominant EGFR mutations were exon 19 deletion (48.6%) and L858R (47.1%). NGS was performed for ~23% of patients. In patients with stage IV disease, third-generation TKI use increased markedly (14.3% in 2022 vs. 91.1% in 2024). Stage III management was notably heterogeneous; definitive concurrent chemoradiotherapy was used in only 15.3% of stage III patients overall, with surgery-based treatment predominating in stage IIIA and systemic therapy accounting for all treatment in stage IIIC. The 3-year overall survival rates were 97.2%, 90.9%, 78.3%, and 58.4% for stages I-IV, respectively. Conclusion: This nationwide registry analysis reveals rapid adoption of third-generation TKIs in metastatic EGFR-mutant NSCLC and substantial heterogeneity in stage III disease management. These findings provide clinically meaningful insights into the evolving treatment paradigm of EGFR-mutant NSCLC across disease stages in routine practice.
Language: English
Field: Medicine
Open Access status: diamond
Funder: Yuhan
OpenAlex ID: W7235900082
FWCI:
Cites: 28
Cited by:
Related to: 10